Sincoñegue, Leah Jean .

HRN: 27-20-19  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2025
CEFUROXIME 1.5GM (VIAL)
05/26/2025
05/27/2025
IV
1.5g
Q8 X 3 Doses
Uti
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: